Return On Equity of Forte Biosciences, Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Forte Biosciences, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • Forte Biosciences, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -76%, a 50% increase year-over-year.
  • Forte Biosciences, Inc. annual Return On Equity for 2024 was -132%, a 40% decline from 2023.
  • Forte Biosciences, Inc. annual Return On Equity for 2023 was -94%, a 172% decline from 2022.
  • Forte Biosciences, Inc. annual Return On Equity for 2022 was -35%, a 24% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Forte Biosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -76% +76% +50% 01 Jul 2025 30 Sep 2025
Q2 2025 -85% +32% +28% 01 Apr 2025 30 Jun 2025
Q1 2025 -149% -50% -50% 01 Jan 2025 31 Mar 2025
Q4 2024 -132% -38% -40% 01 Oct 2024 31 Dec 2024
Q3 2024 -151% -62% -70% 01 Jul 2024 30 Sep 2024
Q2 2024 -118% -49% -72% 01 Apr 2024 30 Jun 2024
Q1 2024 -99% -52% -110% 01 Jan 2024 31 Mar 2024
Q4 2023 -94% -60% -172% 01 Oct 2023 31 Dec 2023
Q3 2023 -89% -59% -193% 01 Jul 2023 30 Sep 2023
Q2 2023 -69% -28% -68% 01 Apr 2023 30 Jun 2023
Q1 2023 -47% -3% -6.3% 01 Jan 2023 31 Mar 2023
Q4 2022 -35% +11% +24% 01 Oct 2022 31 Dec 2022
Q3 2022 -30% +14% +31% 01 Jul 2022 30 Sep 2022
Q2 2022 -41% +3% +7.4% 01 Apr 2022 30 Jun 2022
Q1 2022 -44% +80% +64% 01 Jan 2022 31 Mar 2022
Q4 2021 -46% +145% +76% 01 Oct 2021 31 Dec 2021
Q3 2021 -44% +580% +93% 01 Jul 2021 30 Sep 2021
Q2 2021 -44% +1860% +98% 01 Apr 2021 30 Jun 2021
Q1 2021 -124% -446% -138% 01 Jan 2021 31 Mar 2021
Q4 2020 -191% -611% -145% 01 Oct 2020 31 Dec 2020
Q3 2020 -624% -1672% -160% 01 Jul 2020 30 Sep 2020
Q2 2020 -1904% -1699% -827% 01 Apr 2020 30 Jun 2020
Q1 2020 322% +486% 01 Jan 2020 31 Mar 2020
Q4 2019 420% +548% 01 Oct 2019 31 Dec 2019
Q3 2019 1048% +1120% 01 Jul 2019 30 Sep 2019
Q2 2019 -205% -128% -165% 01 Apr 2019 30 Jun 2019
Q1 2019 -164% -107% -187% 01 Jan 2019 31 Mar 2019
Q4 2018 -128% +18% +12% 01 Oct 2018 31 Dec 2018
Q3 2018 -72% -236% -143% 01 Jul 2018 30 Sep 2018
Q2 2018 -77% 01 Apr 2018 30 Jun 2018
Q1 2018 -57% 01 Jan 2018 31 Mar 2018
Q4 2017 -146% 01 Oct 2017 31 Dec 2017
Q3 2017 165% 01 Jul 2017 30 Sep 2017

Forte Biosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -132% -38% -40% 01 Jan 2024 31 Dec 2024
2023 -94% -60% -172% 01 Jan 2023 31 Dec 2023
2022 -35% +11% +24% 01 Jan 2022 31 Dec 2022
2021 -46% +145% +76% 01 Jan 2021 31 Dec 2021
2020 -191% -321% -246% 01 Jan 2020 31 Dec 2020
2019 131% +259% 01 Jan 2019 31 Dec 2019
2018 -128% +18% +12% 01 Jan 2018 31 Dec 2018
2017 -146% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.